Search Results
Clinical Medical College, North Sichuan Medical College, Nanchong, Sichuan, China
Search for other papers by Shaodong Hou in
Google Scholar
PubMed
Search for other papers by Yiceng Sun in
Google Scholar
PubMed
Search for other papers by Zeyu Yang in
Google Scholar
PubMed
Search for other papers by Mi Tang in
Google Scholar
PubMed
Search for other papers by Tingjie Yin in
Google Scholar
PubMed
Search for other papers by Cong Shao in
Google Scholar
PubMed
Search for other papers by Cunye Yan in
Google Scholar
PubMed
Search for other papers by Linlong Mo in
Google Scholar
PubMed
Search for other papers by Yuquan Yuan in
Google Scholar
PubMed
Search for other papers by Supeng Yin in
Google Scholar
PubMed
Clinical Medical College, North Sichuan Medical College, Nanchong, Sichuan, China
Search for other papers by Fan Zhang in
Google Scholar
PubMed
Introduction By 2020, thyroid cancer had ranked as the fifth most prevalent cancer in women and the 11th most common cancer overall, with a sharp increase in its frequency worldwide ( 1 ). Papillary thyroid carcinoma (PTC) is the most common
Search for other papers by Stéphane Bardet in
Google Scholar
PubMed
Search for other papers by Renaud Ciappuccini in
Google Scholar
PubMed
Search for other papers by Livia Lamartina in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
selpercatinib. Introduction Serum tumour markers are important tools in the management of patients with medullary thyroid carcinoma (MTC) ( 1 ). Serum calcitonin (CT) and carcinoembryonic antigen (CEA) are produced by neoplastic C-cells, and their
College of Medicine, Yonsei University, Seoul, Republic of Korea
Search for other papers by Jihwan Yoo in
Google Scholar
PubMed
Search for other papers by Hee Jun Kim in
Google Scholar
PubMed
Search for other papers by Seok Mo Kim in
Google Scholar
PubMed
Search for other papers by Hun Ho Park in
Google Scholar
PubMed
Introduction Patients with differentiated thyroid cancer (DTC) generally have a good prognosis, even in cases of stage IV disease. The 10-year disease-specific survival rate is 82.6%, which is longer than that among patients with other
Search for other papers by Andrea Leoncini in
Google Scholar
PubMed
Search for other papers by Chiara Camponovo in
Google Scholar
PubMed
Faculty of Biomedical Sciences, Università Della Svizzera Italiana, Lugano, Switzerland
Search for other papers by Gaetano Paone in
Google Scholar
PubMed
Search for other papers by Elena Gamarra in
Google Scholar
PubMed
Faculty of Biomedical Sciences, Università Della Svizzera Italiana, Lugano, Switzerland
Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland
Search for other papers by Giorgio Treglia in
Google Scholar
PubMed
Faculty of Biomedical Sciences, Università Della Svizzera Italiana, Lugano, Switzerland
Search for other papers by Pierpaolo Trimboli in
Google Scholar
PubMed
Introduction Thyroid nodule (TN) is a common pathological condition requiring a specific diagnostic workup ( 1 ). The first step in diagnosing thyroid disorders is to conduct a physical examination of the thyroid gland, followed by laboratory
Search for other papers by Jaume Capdevila in
Google Scholar
PubMed
Search for other papers by Desiree’ Deandreis in
Google Scholar
PubMed
Search for other papers by Cosimo Durante in
Google Scholar
PubMed
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
Search for other papers by Markus Luster in
Google Scholar
PubMed
Search for other papers by Romana Netea-Maier in
Google Scholar
PubMed
Search for other papers by Kate Newbold in
Google Scholar
PubMed
Search for other papers by Susanne Singer in
Google Scholar
PubMed
Search for other papers by Gerasimos P Sykiotis in
Google Scholar
PubMed
Search for other papers by Beate Bartes in
Google Scholar
PubMed
Search for other papers by Kate Farnell in
Google Scholar
PubMed
Department of Internal Medicine and Therapeutics, University of Pavia, Italy
Search for other papers by Laura Deborah Locati in
Google Scholar
PubMed
Introduction The incidence of thyroid cancer (TC) has steadily increased by 20% from 1990 to 2013 and is now predicted to be the fourth leading type of cancer globally ( 1 ). The increase has been ascribed primarily to the ability to detect
Search for other papers by Diana Borges Duarte in
Google Scholar
PubMed
Search for other papers by Vânia Benido Silva in
Google Scholar
PubMed
Search for other papers by Guilherme Assunção in
Google Scholar
PubMed
Search for other papers by André Couto Carvalho in
Google Scholar
PubMed
Search for other papers by Cláudia Freitas in
Google Scholar
PubMed
Introduction Differentiated thyroid carcinoma (DTC) is the most common endocrine gland malignancy, most frequently diagnosed among women between the ages of 45 and 54 years ( 1 , 2 ). Despite the increasing incidence worldwide over the last
Search for other papers by Sang-Hyeon Ju in
Google Scholar
PubMed
Search for other papers by Yong Bae Ji in
Google Scholar
PubMed
Search for other papers by Minchul Song in
Google Scholar
PubMed
Search for other papers by Joung Youl Lim in
Google Scholar
PubMed
Search for other papers by Da Beom Heo in
Google Scholar
PubMed
Search for other papers by Min-Gyu Kim in
Google Scholar
PubMed
Department of Otorhinolaryngology–Head and Neck Surgery, Chungnam National University College of Medicine, Daejeon, Republic of Korea
Search for other papers by Jae Won Chang in
Google Scholar
PubMed
Department of Otorhinolaryngology–Head and Neck Surgery, Chungnam National University Sejong Hospital, Sejong, Republic of Korea
Search for other papers by Ho-Ryun Won in
Google Scholar
PubMed
Search for other papers by Yea Eun Kang in
Google Scholar
PubMed
Search for other papers by Eu Jeong Ku in
Google Scholar
PubMed
Search for other papers by Mijin Kim in
Google Scholar
PubMed
Search for other papers by Eun Kyung Lee in
Google Scholar
PubMed
Search for other papers by June Young Choi in
Google Scholar
PubMed
Search for other papers by Hyeong Won Yu in
Google Scholar
PubMed
Search for other papers by Young Joo Park in
Google Scholar
PubMed
Search for other papers by Jun-Ho Choe in
Google Scholar
PubMed
Department of Otorhinolaryngology–Head and Neck Surgery, Chungnam National University College of Medicine, Daejeon, Republic of Korea
Search for other papers by Bon Seok Koo in
Google Scholar
PubMed
Search for other papers by the MASTER study group † in
Google Scholar
PubMed
Introduction Thyroid cancer, which is the most common endocrine malignancy, has been increasing globally ( 1 , 2 ). From 1990 to 2017, the annual age-standardized incidence rate (ASIR) of thyroid cancer worldwide increased from 2.11 to 3
Department of Nuclear Medicine, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China
Search for other papers by Junyu Tong in
Google Scholar
PubMed
Department of Nuclear Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, People’s Republic of China
Search for other papers by Maomei Ruan in
Google Scholar
PubMed
Search for other papers by Yuchen Jin in
Google Scholar
PubMed
Search for other papers by Hao Fu in
Google Scholar
PubMed
Search for other papers by Lin Cheng in
Google Scholar
PubMed
Search for other papers by Qiong Luo in
Google Scholar
PubMed
Department of Pathology, Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai, People’s Republic of China
Search for other papers by Zhiyan Liu in
Google Scholar
PubMed
Search for other papers by Zhongwei Lv in
Google Scholar
PubMed
Search for other papers by Libo Chen in
Google Scholar
PubMed
Introduction The incidence of thyroid cancer, the most common endocrine malignancy, has been increasing over the past decades. More than 87% of thyroid cancers are distinguished as differentiated thyroid carcinoma (DTC), including papillary
Search for other papers by Jiahui Wu in
Google Scholar
PubMed
Search for other papers by Xunyang Hu in
Google Scholar
PubMed
Department of Radiology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Paula Seal in
Google Scholar
PubMed
Search for other papers by Parthiv Amin in
Google Scholar
PubMed
Mayfair Radiology, Calgary, Alberta, Canada
Search for other papers by Brendan Diederichs in
Google Scholar
PubMed
Departments of Medicine, Oncology, Pathology and Laboratory Medicine, Biochemistry and Molecular Biology, and Arnie Charbonneau Cancer Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
Introduction Current postoperative follow-up (FU) and dynamic response to treatment (RTT) assessment of thyroid cancer primarily depends on postoperative neck ultrasound (POU) and thyroglobulin (Tg) determination ( 1 ). This FU strategy is
University of Geneva, Faculty of Medicine, Rue Michel Servet, Geneva, Switzerland
Search for other papers by Maria Mavromati in
Google Scholar
PubMed
Search for other papers by Verdiana Caironi in
Google Scholar
PubMed
University of Geneva, Faculty of Medicine, Rue Michel Servet, Geneva, Switzerland
Search for other papers by Essia Saiji in
Google Scholar
PubMed
University of Geneva, Faculty of Medicine, Rue Michel Servet, Geneva, Switzerland
Search for other papers by Maria-Isabel Vargas in
Google Scholar
PubMed
University of Geneva, Faculty of Medicine, Rue Michel Servet, Geneva, Switzerland
Search for other papers by Shahan Momjian in
Google Scholar
PubMed
Search for other papers by Stephanie Andrade-Lopes in
Google Scholar
PubMed
Search for other papers by Capucine Gubert in
Google Scholar
PubMed
Search for other papers by Marco Stefano Demarchi in
Google Scholar
PubMed
Search for other papers by Ismini Mainta in
Google Scholar
PubMed
University of Geneva, Faculty of Medicine, Rue Michel Servet, Geneva, Switzerland
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
University of Geneva, Faculty of Medicine, Rue Michel Servet, Geneva, Switzerland
Search for other papers by Kaveh Samii in
Google Scholar
PubMed
Service of Hematology and Laboratory of Hematology, Institut Central des Hôpitaux, Hôpital du Valais, Av. du Grand-Champsec, Sion, Switzerland
Search for other papers by Grégoire Stalder in
Google Scholar
PubMed
University of Geneva, Faculty of Medicine, Rue Michel Servet, Geneva, Switzerland
Search for other papers by Sophie Leboulleux in
Google Scholar
PubMed
reports exist on thyroid involvement in LCH, mostly associated with multisystemic disease. Novel insights The prevalence of thyroid involvement in LCH could be underestimated as clinical and radiological findings are nonspecific